Cargando…

Bone-Targeted Agents and Metastasis Prevention

SIMPLE SUMMARY: Bone metastases are common in cancer patients and the role of bone-targeted agents in prevention of metastasis have been evaluated in multiple clinical trials over the past 20 years. Results show that in breast cancer the use of adjuvant bisphosphonates (and possibly denosumab) reduc...

Descripción completa

Detalles Bibliográficos
Autor principal:	Coleman, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367604/ https://www.ncbi.nlm.nih.gov/pubmed/35892899 http://dx.doi.org/10.3390/cancers14153640

Ejemplares similares

Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer
por: D’Oronzo, Stella, et al.
Publicado: (2020)

New agents for bone metastasis
por: Hortobagyi, GN
Publicado: (2005)

Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management
por: D'Oronzo, Stella, et al.
Publicado: (2018)

Bone Targeted Therapies for Bone Metastasis in Breast Cancer
por: Razaq, Wajeeha
Publicado: (2013)

The Osteoclast in Bone Metastasis: Player and Target
por: Maurizi, Antonio, et al.
Publicado: (2018)

Targeted Nanomedicine to Treat Bone Metastasis
por: Adjei, Isaac M., et al.
Publicado: (2018)

Bone-targeted agents in multiple myeloma
por: Nishida, Hiroko
Publicado: (2018)

Targeting lymphangiogenesis to prevent tumour metastasis
por: Achen, M G, et al.
Publicado: (2006)

Targeting Agents in Biomaterial-Mediated Bone Regeneration
por: Gisbert-Garzarán, Miguel, et al.
Publicado: (2023)

Bone-Targeted Agents for the Management of Breast Cancer Patients with Bone Metastases
por: Simos, Demetrios, et al.
Publicado: (2013)

The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis
por: Hadji, P., et al.
Publicado: (2012)

Development of Molecularly Targeted Agents and Immunotherapies in Glioblastoma: A Personalized Approach
por: Coleman, Niamh, et al.
Publicado: (2018)

Targeting Bone Metastasis in Cancers
por: Bonnelye, Edith, et al.
Publicado: (2021)

Galectin-3 as a Potential Target to Prevent Cancer Metastasis
por: Ahmed, Hafiz, et al.
Publicado: (2015)

Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis
por: Kähkönen, Tiina E., et al.
Publicado: (2021)

Where Do Bone-Targeted Agents RANK in Breast Cancer Treatment?
por: von Moos, Roger, et al.
Publicado: (2013)

Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the Art
por: Mollica, Veronica, et al.
Publicado: (2021)

Bone Metastasis
por: Moore, J. V., et al.
Publicado: (1982)

The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and Treatment
por: Demirkan, Binnaz
Publicado: (2013)

Tumor metastasis to bone
por: Virk, Mandeep S, et al.
Publicado: (2007)

Estrogen-Related Receptor α: A Significant Regulator and Promising Target in Bone Homeostasis and Bone Metastasis
por: Feng, Chun, et al.
Publicado: (2022)

Tumor dormancy: potential therapeutic target in tumor recurrence and metastasis prevention
por: Wang, Sih-han, et al.
Publicado: (2013)

From latency to overt bone metastasis in breast cancer: potential for treatment and prevention
por: Salvador, Fernando, et al.
Publicado: (2019)

Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection
por: Zeisel, Mirjam B., et al.
Publicado: (2015)

Molecular targets of pomegranate (Punica granatum) in preventing cancer metastasis
por: Ahmadiankia, Naghmeh
Publicado: (2019)

Bone targeted treatments in cancer – The story so far
por: Coleman, Robert
Publicado: (2016)

Molecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside?
por: Casimiro, Sandra, et al.
Publicado: (2016)

Bone Targeting Agents in Patients with Prostate Cancer: General Toxicities and Osteonecrosis of the Jaw
por: Mollica, Veronica, et al.
Publicado: (2022)

From Prostate to Bone: Key Players in Prostate Cancer Bone Metastasis
por: Thobe, Megan N., et al.
Publicado: (2011)

The role of the bone microenvironment in skeletal metastasis
por: Zheng, Yu, et al.
Publicado: (2012)

Bone Metastasis in Bladder Cancer
por: Yi, Lei, et al.
Publicado: (2022)

Bone Microenvironment and Osteosarcoma Metastasis
por: Yang, Chaofei, et al.
Publicado: (2020)

Trends in Bone Metastasis Modeling
por: Laranga, Roberta, et al.
Publicado: (2020)

Extracellular Vesicles in Bone Metastasis: Key Players in the Tumor Microenvironment and Promising Therapeutic Targets
por: Tamura, Takaaki, et al.
Publicado: (2020)

Breast cancer metastasis to the bone: mechanisms of bone loss
por: Chen, Yu-Chi, et al.
Publicado: (2010)

The history of cancer pain and bone-targeted agents: 10 most commonly asked questions
por: Vieira, Cláudia Margarida Pereira, et al.
Publicado: (2018)

Bone-Targeted Agents in Breast Cancer: Do We Now Have All the Answers?
por: Ottewell, Penny, et al.
Publicado: (2019)

The role of bone‐modifying agents in myeloma bone disease
por: Lu, Huifang, et al.
Publicado: (2021)

Use of bone-modifying agents among breast cancer patients with bone metastasis: evidence from oncology practices in the US
por: McGrath, Leah J, et al.
Publicado: (2018)

A systematic review of dosing frequency with bone-targeted agents for patients with bone metastases from breast cancer
por: Hutton, Brian, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9h6eggoi1bo27vqn0u7gc5mio9